comparemela.com

Latest Breaking News On - Josh rappaport - Page 8 : comparemela.com

Theseus Pharmaceuticals to Participate in the Cantor Future of Oncology Virtual Symposium

/PRNewswire/ Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) ("Theseus"), a clinical-stage biopharmaceutical company focused on improving the lives of cancer.

United kingdomUnited statesJosh rappaportChristen baglaneasTheseus pharmaceuticalsPrnewswire theseus pharmaceuticals incCorporate communications investor relationsTheseus pharmaceuticals incPanel date timeCantor futureOncology virtual symposiumOncology virtualCorporate communications

Theseus Pharmaceuticals to Participate in the SVB Securities Global Biopharma Conference

/PRNewswire/ Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) ("Theseus"), a clinical-stage biopharmaceutical company focused on improving the lives of cancer.

United kingdomUnited statesJosh rappaportChristen baglaneasTheseus pharmaceuticalsCorporate communications investor relationsPrnewswire theseus pharmaceuticals incTheseus pharmaceuticals incGlobal biopharma conferenceGlobal biopharmaChat dateCorporate communications

Theseus Pharmaceuticals Highlights Key Anticipated 2023 Milestones and Announces BCR-ABL as Target for Third Development Program

/PRNewswire/ Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) (Theseus or the Company), a clinical-stage biopharmaceutical company focused on improving the.

United statesUnited kingdomTim clacksonJosh rappaportAmy jobeChristen baglaneasExchange commissionLifesci communicationsTheseus pharmaceuticalsDrug administrationPrnewswire theseus pharmaceuticals incTheseus pharmaceuticals incProgressing phaseChief executive officerBill shakespeareTheseu form

Theseus Pharmaceuticals Appoints Steven Stein, M D to Board of Directors

/PRNewswire/ Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) (Theseus or the Company), a clinical-stage biopharmaceutical company focused on improving the.

South africaUnited statesUnited kingdomTim clacksonJosh rappaportSteven steinAmy jobeChristen baglaneasPrnewswire theseus pharmaceuticals incTheseus pharmaceuticals incExchange commissionTheseus pharmaceuticalsLifesci communicationsNovartis pharmaceuticals corporationUniversity of pennsylvaniaHead of medicines development for hematology

Theseus Pharmaceuticals to Participate at Upcoming September Investor Conferences

/PRNewswire/ Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) (Theseus or the Company), a clinical-stage biopharmaceutical company focused on improving the.

United kingdomJosh rappaportAmy jobeChristen baglaneasMorgan stanleyCompany presentationPanel discussionPrnewswire theseus pharmaceuticals incTheseus pharmaceuticals incCantor fitzgeraldTheseus pharmaceuticalsLifesci communicationsAnnual global investmentAnnual global healthcare conferenceHealth care amp hospitalsMedical pharmaceuticals

vimarsana © 2020. All Rights Reserved.